Congenital neuroblastoma in a patient with partial trisomy of 2p

J Pediatr Hematol Oncol. 2006 Jun;28(6):379-82. doi: 10.1097/00043426-200606000-00011.

Abstract

We report the fourth example of a patient with germline partial trisomy of 2p21-pter and congenital neuroblastoma. The male infant had a dysmorphic facial expression and presented with congenital heart disease, supernumerary nipples, hypospadias, shawl scrotum, hemilateral persistent hyperplastic primary vitreous, and neuroblastoma. His germline karyotype of 46,XY,der(8)t(2;8)(p21;p23.2) was inherited from a maternal-balanced translocation, which indicates that the proto-oncogene MYCN region of 2p24.3 is tripicated in germline cells. A cytogenetic study of the biopsied tumor cells did not show MYCN amplification, but the DNA index was 2.4 and histologic fluorescent in situ hybridization analysis indicated somatic mutation with near-pentaploidy of the tumor cells. This could be an alternative mechanism of MYCN activation in the process of the tumorigenesis of neuroblastoma.

Publication types

  • Case Reports

MeSH terms

  • Abnormalities, Multiple* / pathology
  • Biopsy
  • Chromosomes, Human, Pair 2*
  • Gene Amplification*
  • Humans
  • In Situ Hybridization
  • Infant, Newborn
  • Male
  • N-Myc Proto-Oncogene Protein
  • Neuroblastoma / congenital*
  • Neuroblastoma / genetics*
  • Neuroblastoma / pathology
  • Nuclear Proteins / genetics*
  • Oncogene Proteins / genetics*
  • Proto-Oncogene Mas
  • Trisomy*

Substances

  • MAS1 protein, human
  • MYCN protein, human
  • N-Myc Proto-Oncogene Protein
  • Nuclear Proteins
  • Oncogene Proteins
  • Proto-Oncogene Mas